← Back to Search

Contact Lens

Test/Control for Visual Acuity

N/A

Waitlist Available

Research Sponsored by Johnson & Johnson Vision Care, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 15 minutes after lens insertion

Awards & highlights

Study Summary

This trial tests 2 treatments on 4 visits to compare effectiveness. Masked to protect privacy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 15 minutes after lens insertion

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~15 minutes after lens insertion

This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 minutes after lens insertion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptable Lens Fit

Rotation Stability with blinks

Slit Lamp Findings (SLF)

+3 more

Secondary outcome measures

CLUE Comfort score

CLUE Handling score

Trial Design

2Treatment groups

Experimental Treatment

Group I: Test/ControlExperimental Treatment2 Interventions

Eligible subjects who are habitual soft contact lens wearers will be randomized into the Test/Control sequence, to wear bilaterally two different study lenses, one at a time, for a minimum of 8 hours per day for at least 5 days during each wear period, over two wear periods (test then control) with a washout period of 7+/-2 days duration between wear periods.

Group II: Control/TestExperimental Treatment2 Interventions

Eligible subjects who are habitual soft contact lens wearers will be randomized into the Control/Test sequence, to wear bilaterally two different study lenses, one at a time, for a minimum of 8 hours per day for at least 5 days during each wear period, over two wear periods (control then test) with a washout period of 7+/-2 days duration between wear periods.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Acuvue Oasys 1 Day for Astigmatism

2023

N/A

~190

TRA100/TRA200 series toric contact lens with HEVL-blocking chromophore

2023

N/A

~190

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Johnson & Johnson Vision Care, Inc.Lead Sponsor

216 Previous Clinical Trials

25,373 Total Patients Enrolled

87 Trials studying Visual Acuity

8,588 Patients Enrolled for Visual Acuity

Johnson & Johnson Vision Care, Inc. Clinical TrialStudy DirectorJohnson & Johnson Vision Care, Inc.

44 Previous Clinical Trials

4,247 Total Patients Enrolled

33 Trials studying Visual Acuity

3,617 Patients Enrolled for Visual Acuity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experimental protocol allowing for seniors to participate?

"In order to be considered for this trial, prospective candidates must fall within the 18-39 age bracket. Those younger than 18 or over 65 can find alternative trials that cater to their demographics."

Answered by AI

Who meets the eligibility criteria for participating in this research trial?

"In order to participate in this research, candidates must possess a certain level of visual acuity and be between 18-39 years old. The investigators are currently recruiting circa 180 participants."

Answered by AI

Are there a multitude of medical facilities in America currently administering this research?

"Currently, 10 clinical trial sites are hosting this medical study. These locations can be found in the cities of Longwood, Maitland and Medina among other places. To avoid extensive travelling, potential participants should pick a site that is close to their home address."

Answered by AI

Is enrollment for this research program still available?

"Per the information on clinicaltrials.gov, this medical study is not currently enrolling patients. Initially posted in March 13th 2023 and last modified on March 10th 2023, it does not appear that participants are being sought for this trial at present. Nonetheless, 3 other studies remain open to enrolment presently."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Design Validation of Toric Contact Lenses in Senofilcon A With a Blue-Blocking Chromophore

2023. "Design Validation of Toric Contact Lenses in Senofilcon A With a Blue-Blocking Chromophore". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05778786.